Full 4th Circuit to rehear challenges to state contract pharmacy laws 

May 29, 2026 - 01:28 PM
340B-court-update

The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge panel from that court found those laws to be unconstitutional. At the time of those decisions, AHA General Counsel Chad Golder stated, they “scream out for rehearing by the full Fourth Circuit. As the dissenting judge correctly points out, the majority rests its decision on arguments that the parties never made. It invents new theories of preemption that lack any basis in the law. It conflicts with the decisions of courts across the country. And it is wrong. We look forward to it being overturned.”  

The full court of appeals will now reconsider those decisions. Two federal courts of appeals have upheld similar laws in Louisiana and Arkansas. The AHA filed amicus briefs in support of the West Virginia and Maryland laws in both the district court and the 4th Circuit. 

Related News Articles

Headline
AHA challenges HRSA’s burden estimate for proposed 340B rebate model
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
AHA urges court to reject AbbVie bid to change 340B program rules
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit …
Headline
HRSA announces 340B program sales reached $100 billion in CY 2025
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…
Perspective
Keeping Patient Access Front and Center in Washington
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
CMS proposes increases to Medicare hospital outpatient department payment rates, site-neutral and 340B changes
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
Eli Lilly moves to deny 340B pricing over data requirements; AHA urges federal action
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…